bioMerieux's market cap is currently €13.55B. The company's EPS TTM is €3.484; its P/E ratio is 32.89; and it has a dividend yield of 0.75%. bioMerieux is scheduled to report earnings on March 7, 2025, and the estimated EPS forecast is €2.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	€ 3.67B	€ 3.59B	€ 3.38B	€ 3.12B	€ 2.67B
Gross Profit	€ 2.06B	€ 1.96B	€ 1.97B	€ 1.74B	€ 1.45B
Operating Income	€ 439.10M	€ 559.80M	€ 768.00M	€ 551.20M	€ 330.90M
EBITDA	€ 700.80M	€ 811.90M	€ 977.80M	€ 747.70M	€ 548.20M
Net Income	€ 357.60M	€ 452.40M	€ 601.10M	€ 404.40M	€ 272.80M
Balance Sheet
Cash & Short-Term Investments	€ 352.40M	€ 552.60M	€ 803.50M	€ 389.20M	€ 275.00M
Total Assets	€ 5.26B	€ 5.19B	€ 4.61B	€ 3.93B	€ 3.78B
Total Debt	€ 518.80M	€ 505.40M	€ 462.50M	€ 481.30M	€ 592.30M
Net Debt	€ 166.40M	€ -47.20M	€ -341.00M	€ 92.10M	€ 317.30M
Total Liabilities	€ 1.51B	€ 1.54B	€ 1.44B	€ 1.45B	€ 1.53B
Stockholders' Equity	€ 3.75B	€ 3.60B	€ 3.11B	€ 2.43B	€ 2.20B
Cash Flow
Free Cash Flow	€ 107.10M	€ 188.40M	€ 534.60M	€ 305.30M	€ 135.40M
Operating Cash Flow	€ 445.40M	€ 475.10M	€ 824.70M	€ 582.80M	€ 407.90M
Investing Cash Flow	€ -488.80M	€ -528.10M	€ -307.30M	€ -266.00M	€ -305.70M
Financing Cash Flow	€ -122.30M	€ -244.20M	€ -140.60M	€ -175.40M	€ -110.40M

Currency in EUR

bioMerieux Earnings and Revenue History

Income Statement >

bioMerieux Debt to Assets

Balance Sheet >

bioMerieux Cash Flow

Cash Flow >

bioMerieux Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing